ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Biotech companies at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
85 biotech companies are at ACR Convergence 2026 — 96 presentations on the program and 23 with a booth in the exhibit hall. Most represented: argenx (2 on the program), Imviva Bio (2 on the program), Cabaletta Bio (2 on the program). 34 of them have their own page in this guide. As of Nov 2, 2026.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
A biotechnology company developing antibody-based medicines for autoimmune diseases. | Booth Exhibiting at Booth 1717 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Talk Sun Nov 8 1:30pm–1:45pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 5:30pm–7:30pm Autoimmune Myositis Reframed: New Perspectives on Burden, Biology and Clinical Outcomes Industry Tue Nov 10 5:30pm–7:30pm IIMagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes |
A biotechnology company developing allogeneic CAR T-cell therapies for autoimmune diseases. | Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Cabaletta Bio Philadelphia, PA | |
A clinical-stage biotechnology company developing engineered T-cell therapies for autoimmune diseases. | Booth Exhibiting at Booth 4104 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Tue Nov 10 1:30pm–2:15pm Designed for Autoimmunity: Rese-cel and the RESET Clinical Program |
Alumis South San Francisco, CA | |
A biotechnology company developing targeted therapies for immune-mediated diseases. | Booth Exhibiting at Booth 3933 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm |
Fate Therapeutics San Diego, CA | |
A clinical-stage biotechnology company developing engineered cell therapies. | Booth Exhibiting at Booth 2631-CT Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Spyre Therapeutics Waltham, MA | |
A clinical-stage biotechnology company developing therapies for inflammatory diseases. | Booth Exhibiting at Booth 2933-CT Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
A biotechnology company applying computational biology to autoimmune disease drug development. | Poster Tue Nov 10 10:30am–12:30pm |
Arcus Biosciences Hayward, CA | |
A clinical-stage biopharmaceutical company developing cancer and immunology medicines. | Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm |
A biotechnology company developing medicines for autoimmune and inflammatory diseases. | Talk Sun Nov 8 9:45am–10:00am Poster Mon Nov 9 10:30am–12:30pm |
A biopharmaceutical company developing antibody-based medicines. | Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Forward Therapeutics Boston, MA | |
Clinical-stage biotechnology company developing oral small-molecule therapies for inflammation-driven diseases. | Poster Sun Nov 8 10:30am–12:30pm |
Therorna Shanghai, China | |
Biotechnology company developing circular RNA therapies for oncology and autoimmune diseases. | Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm |
Find buyers from biotech companies
Tell us what you sell and we’ll find the people at these biotech companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ACR Convergence 2026 by
- Lupus and antiphospholipid syndrome 248
- Rheumatoid arthritis 209
- Epidemiology and outcomes research 209
- Spondyloarthritis and psoriatic arthritis 155
- Basic and translational immunology 145
- Patient care and engagement 140
- Education and careers 137
- Vasculitis 135
- Rare and other inflammatory diseases 125
- Systemic sclerosis and scleroderma 122
- Osteoarthritis and bone 107
- Pediatric rheumatology 82
- Imaging and ultrasound 81
- Myositis and muscle disease 80
- Sjögren’s disease 78
- Treatment safety and immunotherapy 64
- Genetics, genomics and proteomics 48
- Gout and crystal arthritis 45
- Pain and fibromyalgia 40
- Practice management 36
- Infection and rheumatic disease 35
- Pregnancy and reproductive health 33
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction